These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12163798)

  • 1. Candidemia as a cause of septic shock and multiple organ failure in nonimmunocompromised patients.
    Hadley S; Lee WW; Ruthazer R; Nasraway SA
    Crit Care Med; 2002 Aug; 30(8):1808-14. PubMed ID: 12163798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients.
    Abraham E; Laterre PF; Garbino J; Pingleton S; Butler T; Dugernier T; Margolis B; Kudsk K; Zimmerli W; Anderson P; Reynaert M; Lew D; Lesslauer W; Passe S; Cooper P; Burdeska A; Modi M; Leighton A; Salgo M; Van der Auwera P;
    Crit Care Med; 2001 Mar; 29(3):503-10. PubMed ID: 11373411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock.
    López A; Lorente JA; Steingrub J; Bakker J; McLuckie A; Willatts S; Brockway M; Anzueto A; Holzapfel L; Breen D; Silverman MS; Takala J; Donaldson J; Arneson C; Grove G; Grossman S; Grover R
    Crit Care Med; 2004 Jan; 32(1):21-30. PubMed ID: 14707556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluconazole improves survival in septic shock: a randomized double-blind prospective study.
    Jacobs S; Price Evans DA; Tariq M; Al Omar NF
    Crit Care Med; 2003 Jul; 31(7):1938-46. PubMed ID: 12847386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group.
    Cohen J; Carlet J
    Crit Care Med; 1996 Sep; 24(9):1431-40. PubMed ID: 8797612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The yeast to hyphal transition following hematogenous candidiasis induces shock and organ injury independent of circulating tumor necrosis factor-alpha.
    Matuschak GM; Lechner AJ
    Crit Care Med; 1997 Jan; 25(1):111-20. PubMed ID: 8989186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in critical illness including sepsis and septic shock: relation to disease severity, multiple organ dysfunction, and mortality.
    Presneill JJ; Waring PM; Layton JE; Maher DW; Cebon J; Harley NS; Wilson JW; Cade JF
    Crit Care Med; 2000 Jul; 28(7):2344-54. PubMed ID: 10921563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Multiple Organ Dysfunction Score as a descriptor of patient outcome in septic shock compared with two other scoring systems.
    Jacobs S; Zuleika M; Mphansa T
    Crit Care Med; 1999 Apr; 27(4):741-4. PubMed ID: 10321663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with the development of septic shock in patients with candidemia: a post hoc analysis from two prospective cohorts.
    Bassetti M; Vena A; Meroi M; Cardozo C; Cuervo G; Giacobbe DR; Salavert M; Merino P; Gioia F; Fernández-Ruiz M; López-Cortés LE; Almirante B; Escolà-Vergé L; Montejo M; Aguilar-Guisado M; Puerta-Alcalde P; Tasias M; Ruiz-Gaitán A; González F; Puig-Asensio M; Marco F; Pemán J; Fortún J; Aguado JM; Soriano A; Carratalá J; Garcia-Vidal C; Valerio M; Sartor A; Bouza E; Muñoz P
    Crit Care; 2020 Mar; 24(1):117. PubMed ID: 32216822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased organ failure in patients with severe SIRS and septic shock treated with the platelet-activating factor antagonist TCV-309: a prospective, multicenter, double-blind, randomized phase II trial. TCV-309 Septic Shock Study Group.
    Poeze M; Froon AH; Ramsay G; Buurman WA; Greve JW
    Shock; 2000 Oct; 14(4):421-8. PubMed ID: 11049104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study.
    Briegel J; Forst H; Haller M; Schelling G; Kilger E; Kuprat G; Hemmer B; Hummel T; Lenhart A; Heyduck M; Stoll C; Peter K
    Crit Care Med; 1999 Apr; 27(4):723-32. PubMed ID: 10321661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group.
    Abraham E; Anzueto A; Gutierrez G; Tessler S; San Pedro G; Wunderink R; Dal Nogare A; Nasraway S; Berman S; Cooney R; Levy H; Baughman R; Rumbak M; Light RB; Poole L; Allred R; Constant J; Pennington J; Porter S
    Lancet; 1998 Mar; 351(9107):929-33. PubMed ID: 9734938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of age on the innate immune response and outcomes after severe sepsis/septic shock in trauma and surgical intensive care unit patients.
    Brakenridge SC; Efron PA; Stortz JA; Ozrazgat-Baslanti T; Ghita G; Wang Z; Bihorac A; Mohr AM; Brumback BA; Moldawer LL; Moore FA
    J Trauma Acute Care Surg; 2018 Aug; 85(2):247-255. PubMed ID: 29613958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality rates in pediatric septic shock with and without multiple organ system failure.
    Kutko MC; Calarco MP; Flaherty MB; Helmrich RF; Ushay HM; Pon S; Greenwald BM
    Pediatr Crit Care Med; 2003 Jul; 4(3):333-7. PubMed ID: 12831416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of lactate/albumin ratio level to organ failure and mortality in severe sepsis and septic shock.
    Wang B; Chen G; Cao Y; Xue J; Li J; Wu Y
    J Crit Care; 2015 Apr; 30(2):271-5. PubMed ID: 25537574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-Term Organ Dysfunction Is Associated With Long-Term (10-Yr) Mortality of Septic Shock.
    Linder A; Lee T; Fisher J; Singer J; Boyd J; Walley KR; Russell JA
    Crit Care Med; 2016 Aug; 44(8):e728-36. PubMed ID: 27428136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Septic shock and multiple organ failure.
    Ruokonen E; Takala J; Kari A; Alhava E
    Crit Care Med; 1991 Sep; 19(9):1146-51. PubMed ID: 1884613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock.
    Nguyen HB; Rivers EP; Knoblich BP; Jacobsen G; Muzzin A; Ressler JA; Tomlanovich MC
    Crit Care Med; 2004 Aug; 32(8):1637-42. PubMed ID: 15286537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The therapeutic efficacy of adjunct therapeutic plasma exchange for septic shock with multiple organ failure: a single-center experience.
    Keith PD; Wells AH; Hodges J; Fast SH; Adams A; Scott LK
    Crit Care; 2020 Aug; 24(1):518. PubMed ID: 32831133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Septic shock of early or late onset: does it matter?
    Roman-Marchant O; Orellana-Jimenez CE; De Backer D; Melot C; Vincent JL
    Chest; 2004 Jul; 126(1):173-8. PubMed ID: 15249459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.